UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of an Organizational Linkage Intervention on Staff Perceptions of Medication-Assisted Treatment and Referral Intentions in Community Corrections

Journal of substance abuse treatment, 2015-03, Vol.50, p.50-58

2015

Volltextzugriff (PDF)

A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners

Journal of substance abuse treatment, 2015-12, Vol.59, p.52-58

2015

Volltextzugriff (PDF)

Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials

Addiction science & clinical practice, 2020-04, Vol.15 (1), p.15-15, Article 15

2020

Volltextzugriff (PDF)

Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine

Addiction science & clinical practice, 2019-12, Vol.14 (1), p.45-11, Article 45

2019

Volltextzugriff (PDF)

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-07, Vol.316 (3), p.282

2016

Volltextzugriff (PDF)

Letter to the Editor regarding: Buprenorphine for opioid use disorder: The role of public funding in its development (by Barenie and Kesselheim, 2020)

Drug and alcohol dependence, 2021-04, Vol.221, p.108644-108644, Article 108644

2021

Volltextzugriff (PDF)

Patient Engagement in and Adaptations to Delivery of Outpatient Care for Opioid Use Disorder During the COVID-19 Pandemic

Psychiatric services (Washington, D.C.), 2024-03, Vol.75 (3), p.258-267

2024

Volltextzugriff (PDF)

Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling

Neuropharmacology, 2022-11, Vol.218, p.109220-109220, Article 109220

2022

Volltextzugriff (PDF)

Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone'

Molecular psychiatry, 2024-05

2024

Volltextzugriff (PDF)

A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry

Drug and alcohol dependence, 2014-09, Vol.142, p.33-40

2014

Volltextzugriff (PDF)

Medication Development for Addictive Disorders: The State of the Science

The American journal of psychiatry, 2005-08, Vol.162 (8), p.1432-1440

2005

Volltextzugriff (PDF)

Cognitive Remediation in the Treatment of Stimulant Abuse Disorders: A Research Agenda

Experimental and clinical psychopharmacology, 2008-12, Vol.16 (6), p.484-497

2008

Volltextzugriff (PDF)

A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release

Drug and alcohol dependence, 2017-03, Vol.172, p.34-42

2017

Volltextzugriff (PDF)

Addiction Medicine Practice-Based Research Network (AMNet): Building Partnerships

Psychiatric services (Washington, D.C.), 2021-07, Vol.72 (7), p.845-847

2021

Volltextzugriff (PDF)

Approaches to the development of medications for the treatment of methamphetamine dependence

Addiction (Abingdon, England), 2007-04, Vol.102 (s1), p.96-106

2007

Volltextzugriff (PDF)

Experience Starting an Addiction Medicine Practice-Based Research Network

Journal of addiction medicine, 2024-07

2024

Volltextzugriff (PDF)

Extended‐release naltrexone (XR‐NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry

Addiction (Abingdon, England), 2018-08, Vol.113 (8), p.1477-1487

2018

Volltextzugriff (PDF)

Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes

Drug and alcohol dependence, 2018-07, Vol.188, p.232-238

2018

Volltextzugriff (PDF)

Electronic cigarettes in adults in outpatient substance use treatment: Awareness, perceptions, use, and reasons for use

The American journal on addictions, 2015-04, Vol.24 (3), p.233-239

2015

Volltextzugriff (PDF)

Extended-release buprenorphine induction in opioid non-tolerant incarcerated individuals

Drug and alcohol dependence reports, 2024-09, Vol.12, p.100261, Article 100261

2024

Volltextzugriff (PDF)

Avatar-assisted therapy: a proof-of-concept pilot study of a novel technology-based intervention to treat substance use disorders

The American journal of drug and alcohol abuse, 2017-09, Vol.43 (5), p.518-524

2017

Volltextzugriff (PDF)

Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence

Current opinion in psychiatry, 2009-05, Vol.22 (3), p.263-268

2009

Volltextzugriff (PDF)

[Commentary] CAN REPLACEMENT THERAPY WORK IN THE TREATMENT OF COCAINE DEPENDENCE? AND WHAT ARE WE REPLACING ANYWAY?

Addiction (Abingdon, England), 2007-12, Vol.102 (12), p.1888-1889

VOCCI, FRANK J.

2007

Volltextzugriff (PDF)

A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment

Contemporary clinical trials, 2019-04, Vol.79, p.21-27

2019

Volltextzugriff (PDF)

Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment

Contemporary clinical trials, 2017-02, Vol.53, p.130-136

2017

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(74)
Buchkapitel
(1)

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(54)
Science & Technology
(54)
Humans
(45)
Substance Abuse
(30)
Psychiatry
(28)
Male
(27)
Female
(23)
Adult
(18)
Drug Abuse
(18)
Cocaine
(15)
Animals
(14)
Middle Aged
(14)
Opioid-Related Disorders - Drug Therapy
(14)
Pharmacology & Pharmacy
(14)
Biological And Medical Sciences
(12)
Drug Addiction
(12)
Medical Sciences
(12)
Substance Abuse Treatment
(11)
Neurosciences & Neurology
(10)
Prisoners
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Effect of an Organizational Linkage Intervention on Staff Perceptions of Medication-Assisted Treatment and Referral Intentions in Community Corrections

A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners

Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials

Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial

Letter to the Editor regarding: Buprenorphine for opioid use disorder: The role of public funding in its development (by Barenie and Kesselheim, 2020)

Patient Engagement in and Adaptations to Delivery of Outpatient Care for Opioid Use Disorder During the COVID-19 Pandemic

Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling

Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone'

A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry

Medication Development for Addictive Disorders: The State of the Science

Cognitive Remediation in the Treatment of Stimulant Abuse Disorders: A Research Agenda

A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release

Addiction Medicine Practice-Based Research Network (AMNet): Building Partnerships

Approaches to the development of medications for the treatment of methamphetamine dependence

Experience Starting an Addiction Medicine Practice-Based Research Network

Extended‐release naltrexone (XR‐NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry

Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes

Electronic cigarettes in adults in outpatient substance use treatment: Awareness, perceptions, use, and reasons for use

Extended-release buprenorphine induction in opioid non-tolerant incarcerated individuals

Avatar-assisted therapy: a proof-of-concept pilot study of a novel technology-based intervention to treat substance use disorders

Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence

[Commentary] CAN REPLACEMENT THERAPY WORK IN THE TREATMENT OF COCAINE DEPENDENCE? AND WHAT ARE WE REPLACING ANYWAY?

A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment

Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment

Suchergebnisse filtern